Leicester Research Archive >
College of Medicine, Biological Sciences and Psychology >
Cell Physiology and Pharmacology, Department of >
Published Articles, Dept. of Cell Physiology and Pharmacology >
Please use this identifier to cite or link to this item:
|Title: ||G Protein Coupling and Signaling Pathway Activation by M1 Muscarinic Acetylcholine Receptor Orthosteric and Allosteric Agonists|
|Authors: ||Thomas, Rachel L.|
Langmead, Christopher J.
Wood, Martyn D.
Challiss, R.A. John
|Issue Date: ||1-Nov-2008|
|Publisher: ||American Society for Pharmacology and Experimental Therapeutics (ASPET)|
|Citation: ||Journal of Pharmacology and Experimental Therapeutics, 2008, 327 (2), pp. 365-374.|
|Abstract: ||The M1 muscarinic acetylcholine (mACh) receptor is among a growing number of G protein-coupled receptors that are able to activate multiple signaling cascades. AC-42 (4-n-butyl-1-[4-(2-methylphenyl)-4-oxo-1-butyl] piperidine) is an allosteric agonist that can selectively activate the M1 mACh receptor in the absence of an orthosteric ligand. Allosteric agonists have the potential to stabilize unique receptor conformations, which may in turn cause differential activation of signal transduction pathways. In the present study, we have investigated the signaling pathways activated by AC-42, its analog 77-LH-28-1 (1-[3-(4-butyl-1-piperidinyl)propyl]-3,4-dihydro-2(1H)-quinolinone), and a range of orthosteric muscarinic agonists [oxotremorine-M (oxo-M), arecoline, and pilocarpine] in Chinese hamster ovary cells recombinantly expressing the human M1 mACh receptor. Each agonist was able to activate Gαq/11-dependent signaling, as demonstrated by an increase in guanosine 5′-O-(3-thiotriphosphate) ([35S]GTPγS) binding to Gαq/11 proteins and total [3H]inositol phosphate accumulation assays in intact cells. All three orthosteric agonists caused significant enhancements in [35S]GTPγS binding to Gαi1/2 subunits over basal; however, neither allosteric ligand produced a significant response. In contrast, both orthosteric and allosteric agonists are able to couple to the Gαs/cAMP pathway, enhancing forskolin-stimulated cAMP accumulation. These data provide support for the concept that allosteric and orthosteric mACh receptor agonists both stabilize receptor conformations associated with Gαq/11- and Gαs-dependent signaling; however, AC-42 and 77-LH-28-1, unlike oxo-M, arecoline, and pilocarpine, do not seem to promote M1 mACh receptor-Gαi1/2 coupling, suggesting that allosteric agonists have the potential to activate distinct subsets of downstream effectors.|
|Description: ||This paper was published as Journal of Pharmacology and Experimental Therapeutics, 2008, 327 (2), pp. 365-374. It is available from http://jpet.aspetjournals.org/content/327/2/365.abstract. Doi: 10.1124/jpet.108.141788|
Metadata only entry
|Appears in Collections:||Published Articles, Dept. of Cell Physiology and Pharmacology|
Files in This Item:
There are no files associated with this item.
Items in LRA are protected by copyright, with all rights reserved, unless otherwise indicated.